Cargando…
Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity
The present research work was designed to prepare Azithromycin (AM)-loaded nano lipid carriers (NLs) for ocular delivery. NLs were prepared by the emulsification–homogenization method and further optimized by the Box Behnken design. AM-NLs were optimized using the independent constraints of homogeni...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140781/ https://www.ncbi.nlm.nih.gov/pubmed/35621552 http://dx.doi.org/10.3390/gels8050255 |
_version_ | 1784715181729775616 |
---|---|
author | Gilani, Sadaf Jamal Jumah, May Nasser bin Zafar, Ameeduzzafar Imam, Syed Sarim Yasir, Mohd Khalid, Mohammad Alshehri, Sultan Ghuneim, Mohammed M. Albohairy, Fatima M. |
author_facet | Gilani, Sadaf Jamal Jumah, May Nasser bin Zafar, Ameeduzzafar Imam, Syed Sarim Yasir, Mohd Khalid, Mohammad Alshehri, Sultan Ghuneim, Mohammed M. Albohairy, Fatima M. |
author_sort | Gilani, Sadaf Jamal |
collection | PubMed |
description | The present research work was designed to prepare Azithromycin (AM)-loaded nano lipid carriers (NLs) for ocular delivery. NLs were prepared by the emulsification–homogenization method and further optimized by the Box Behnken design. AM-NLs were optimized using the independent constraints of homogenization speed (A), surfactant concentration (B), and lipid concentration (C) to obtain optimal NLs (AM-NLop). The selected AM-NLop was further converted into a sol-gel system using a mucoadhesive polymer blend of sodium alginate and hydroxyl propyl methyl cellulose (AM-NLopIG). The sol-gel system was further characterized for drug release, permeation, hydration, irritation, histopathology, and antibacterial activity. The prepared NLs showed nano-metric size particles (154.7 ± 7.3 to 352.2 ± 15.8 nm) with high encapsulation efficiency (48.8 ± 1.1 to 80.9 ± 2.9%). AM-NLopIG showed a more prolonged drug release (98.6 ± 4.6% in 24 h) than the eye drop (99.4 ± 5.3% in 3 h). The ex vivo permeation result depicted AM-NLopIG, AM-IG, and eye drop. AM-NLopIG exhibited significant higher AM permeation (60.7 ± 4.1%) than AM-IG (33.46 ± 3.04%) and eye drop (23.3 ± 3.7%). The corneal hydration was found to be 76.45%, which is within the standard limit. The histopathology and HET-CAM results revealed that the prepared formulation is safe for ocular use. The antibacterial study revealed enhanced activity from the AM-NLopIG. |
format | Online Article Text |
id | pubmed-9140781 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91407812022-05-28 Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity Gilani, Sadaf Jamal Jumah, May Nasser bin Zafar, Ameeduzzafar Imam, Syed Sarim Yasir, Mohd Khalid, Mohammad Alshehri, Sultan Ghuneim, Mohammed M. Albohairy, Fatima M. Gels Article The present research work was designed to prepare Azithromycin (AM)-loaded nano lipid carriers (NLs) for ocular delivery. NLs were prepared by the emulsification–homogenization method and further optimized by the Box Behnken design. AM-NLs were optimized using the independent constraints of homogenization speed (A), surfactant concentration (B), and lipid concentration (C) to obtain optimal NLs (AM-NLop). The selected AM-NLop was further converted into a sol-gel system using a mucoadhesive polymer blend of sodium alginate and hydroxyl propyl methyl cellulose (AM-NLopIG). The sol-gel system was further characterized for drug release, permeation, hydration, irritation, histopathology, and antibacterial activity. The prepared NLs showed nano-metric size particles (154.7 ± 7.3 to 352.2 ± 15.8 nm) with high encapsulation efficiency (48.8 ± 1.1 to 80.9 ± 2.9%). AM-NLopIG showed a more prolonged drug release (98.6 ± 4.6% in 24 h) than the eye drop (99.4 ± 5.3% in 3 h). The ex vivo permeation result depicted AM-NLopIG, AM-IG, and eye drop. AM-NLopIG exhibited significant higher AM permeation (60.7 ± 4.1%) than AM-IG (33.46 ± 3.04%) and eye drop (23.3 ± 3.7%). The corneal hydration was found to be 76.45%, which is within the standard limit. The histopathology and HET-CAM results revealed that the prepared formulation is safe for ocular use. The antibacterial study revealed enhanced activity from the AM-NLopIG. MDPI 2022-04-21 /pmc/articles/PMC9140781/ /pubmed/35621552 http://dx.doi.org/10.3390/gels8050255 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gilani, Sadaf Jamal Jumah, May Nasser bin Zafar, Ameeduzzafar Imam, Syed Sarim Yasir, Mohd Khalid, Mohammad Alshehri, Sultan Ghuneim, Mohammed M. Albohairy, Fatima M. Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity |
title | Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity |
title_full | Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity |
title_fullStr | Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity |
title_full_unstemmed | Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity |
title_short | Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity |
title_sort | formulation and evaluation of nano lipid carrier-based ocular gel system: optimization to antibacterial activity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140781/ https://www.ncbi.nlm.nih.gov/pubmed/35621552 http://dx.doi.org/10.3390/gels8050255 |
work_keys_str_mv | AT gilanisadafjamal formulationandevaluationofnanolipidcarrierbasedoculargelsystemoptimizationtoantibacterialactivity AT jumahmaynasserbin formulationandevaluationofnanolipidcarrierbasedoculargelsystemoptimizationtoantibacterialactivity AT zafarameeduzzafar formulationandevaluationofnanolipidcarrierbasedoculargelsystemoptimizationtoantibacterialactivity AT imamsyedsarim formulationandevaluationofnanolipidcarrierbasedoculargelsystemoptimizationtoantibacterialactivity AT yasirmohd formulationandevaluationofnanolipidcarrierbasedoculargelsystemoptimizationtoantibacterialactivity AT khalidmohammad formulationandevaluationofnanolipidcarrierbasedoculargelsystemoptimizationtoantibacterialactivity AT alshehrisultan formulationandevaluationofnanolipidcarrierbasedoculargelsystemoptimizationtoantibacterialactivity AT ghuneimmohammedm formulationandevaluationofnanolipidcarrierbasedoculargelsystemoptimizationtoantibacterialactivity AT albohairyfatimam formulationandevaluationofnanolipidcarrierbasedoculargelsystemoptimizationtoantibacterialactivity |